MedPath

A study on measurement of KP-607 concentrations in nails (Phase I) Investigation on KP-607 concentrations in nails when applied repeatedly to toenails in patients with onychomycosis.

Phase 1
Completed
Conditions
Onychomycosis
Registration Number
JPRN-jRCT2080224040
Lead Sponsor
KAKEN PHARMACEUTICAL CO., LTD.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
completed
Sex
Male
Target Recruitment
24
Inclusion Criteria

Japanese subjects
The subjects diagnosed with onychomycosis

Exclusion Criteria

Patients who have received corticosteroids or immunosuppressants within a certain period of time before screening period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath